Authors: Fariello, RG

Citation: Rg. Fariello, Pharmacodynamic and pharmacokinetic features of cabergoline: rationale foruse in Parkinson's disease. (vol 55, pg 10, 1998), DRUGS, 61(2), 2001, pp. 196-196

Authors: Fariello, RG Maj, R Marrari, P Beard, D Algate, C Salvati, P

Citation: Rg. Fariello et al., Acute behavioral and EEG effects of NW-1015 on electrically-induced afterdischarge in conscious monkeys, EPILEPSY R, 39(1), 2000, pp. 37-46

Authors: Double, KL Zecca, L Costi, P Mauer, M Griesinger, C Ito, S Ben-Shachar, D Bringmann, G Fariello, RG Riederer, P Gerlach, M

Citation: Kl. Double et al., Structural characteristics of human substantia nigra neuromelanin and synthetic dopamine melanins, J NEUROCHEM, 75(6), 2000, pp. 2583-2589

Authors: Pevarello, P Bonsignori, A Caccia, C Amici, R McArthur, RA Fariello, RG Salvati, P Varasi, M

Citation: P. Pevarello et al., Sodium channel activity and sigma binding of 2-aminopropanamide anticonvulsants, BIOORG MED, 9(17), 1999, pp. 2521-2524

Authors: Salvati, P Maj, R Caccia, C Cervini, MA Fornaretto, MG Lamberti, E Pevarello, P Skeen, GA White, HS Wolf, HH Faravelli, L Mazzanti, M Mancinelli, E Varasi, M Fariello, RG

Citation: P. Salvati et al., Biochemical and electrophysiological studies on the mechanism of action ofPNU-151774E, a novel antiepileptic compound, J PHARM EXP, 288(3), 1999, pp. 1151-1159

Authors: Maj, R Fariello, RG Pevarello, P Varasi, M McArthur, RA Salvati, P

Citation: R. Maj et al., Anticonvulsant activity of PNU-151774E in the amygdala kindled model of complex partial seizures, EPILEPSIA, 40(11), 1999, pp. 1523-1528